Literature DB >> 18651521

Heart failure management in Poland: The National Cardiovascular Disease Prevention and Treatment Program POLKARD, edition 2003-2005.

Małgorzata Fedyk-Łukasik, Tomasz Zdrojewski, Barbara Wizner, Grzegorz Opolski, Jacek Dubiel, Małgorzata Stompór, Bogdan Wyrzykowski, Irina Mogilnaya, Michał Marchel, Tomasz Grodzicki.   

Abstract

BACKGROUND: The aim of this study was to assess actual management of heart failure (HF) in Poland, both in outpatient clinics and hospitals. METHODS AND
RESULTS: The survey was undertaken between April 21 2005 and December 31 2005 in 796 outpatient departments and 258 internal medicine and cardiology hospital wards chosen at random. In total 3980 HF outpatients and 1294 inpatients were included. Trained nurses performed the questionnaire-based assessment of diagnostic procedures and pharmacotherapy. Heart failure was diagnosed among general practitioners' (GPs) outpatients most frequently, basing on symptoms (64.0%), ECG (47.0%) and chest X-ray (29.9%), while specialists based their diagnosis on symptoms (52.2%) and echocardiography (37.7%). Most HF outpatients and hospital patients were treated with ACE-I (88.3% and 81%, respectively), beta-blockers (68.3% vs. 84.7%) and diuretics (74.4% vs. 90.3%). Spironolactone accounted for 48.3% vs. 56.3% of the patients, while digitalis glycosides 39.2% and 27.4%, respectively. AT-1 blockers were used very rarely (3.5% vs. 2.5%).
CONCLUSIONS: GPs in Poland tend to diagnose HF on clinical grounds while specialists use more diagnostic investigations. Specialists provide higher quality HF care than GPs, both in outpatient clinics and hospitals. Significant progress in HF management has occurred in Poland since previous studies. (Cardiol J 2007; 14: 552-560).

Entities:  

Year:  2007        PMID: 18651521

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  1 in total

1.  Chronic heart failure management in primary healthcare in Poland: Results of a nationwide cross-sectional study.

Authors:  Barbara Wizner; Małgorzata Fedyk-Łukasik; Grzegorz Opolski; Tomasz Zdrojewski; Adam Windak; Marcin Czech; Jacek S Dubiel; Michał Marchel; Krzysztof Rewiuk; Tomasz Rywik; Jerzy Korewicki; Tomasz Grodzicki
Journal:  Eur J Gen Pract       Date:  2017-11-22       Impact factor: 1.904

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.